CAS 4740-24-3
:Ácido 4-(butilamino)benzóico
- 4-n-Butylaminobenzoic acid
- Benzoic acid, 4-(butylamino)-
- Benzoic acid, p-(butylamino)-
- Nsc 44300
- p-Butylaminobenzoic acid
- para-Butylaminobenzoic acid
- 4-(Butylamino)benzoic acid
Tetracaine Related Compound B (4-(Butylamino)benzoic acid)
CAS:Aromatic amino-acids and their esters,other than thoseFórmula:C11H15NO2Cor e Forma:White Cream PowderPeso molecular:193.110284-(Butylamino)benzoic acid
CAS:4-(Butylamino)benzoic acidFórmula:C11H15NO2Pureza:99%Cor e Forma: pale yellow solidPeso molecular:193.2423g/molTetracaine EP Impurity B (Tetracaine USP Related Compound B)
CAS:Fórmula:C11H15NO2Cor e Forma:Pale Brown SolidPeso molecular:193.254-(Butylamino)benzoic Acid
CAS:Produto ControladoFórmula:C11H15NO2Cor e Forma:NeatPeso molecular:193.244-(Butylamino)benzoic Acid
CAS:Produto ControladoApplications 4-(Butylamino)benzoic Acid is an intermediate used to synthesize 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus.
References Masunari, A., et al.: Bioorg. Med. Chem., 15, 4229 (2007);Fórmula:C11H15NO2Cor e Forma:WhitePeso molecular:193.244-(Butylamino)benzoic acid
CAS:4-(Butylamino)benzoic acid is a non-steroidal anti-inflammatory drug (NSAID) that has been used to treat pain. It is a prodrug, which is metabolized in the liver to 4-(butylamino)-phenylacetic acid, its active form. The 4-(butylamino)benzoic acid molecule has a hydrophobic effect and binds to chloride ions. This binding inhibits the production of prostaglandins, which are mediators of pain. 4-(Butylamino)benzoic acid also reduces the activity of plasma cells that produce antibodies and increases the activity of lymphocytes and platelets, leading to an increase in immunoglobulin levels.
Fórmula:C11H15NO2Pureza:Min. 95%Cor e Forma:PowderPeso molecular:193.24 g/molRef: 3D-FB133577
Produto descontinuado










